text:
42 U.S. Code § 1395w–104 - Beneficiary protections for qualified prescription drug coverage
prev | next
(a) Dissemination of information
(1) General information
(A) Application of MA information
A PDP sponsor shall disclose, in a clear, accurate, and standardized form to each enrollee with a prescription drug plan offered by the sponsor under this part at the time of enrollment and at least annually thereafter, the information described in section 1395w–22 (c)(1) of this title relating to such plan, insofar as the Secretary determines appropriate with respect to benefits provided under this part, and including the information described in subparagraph (B).
(B) Drug specific information
The information described in this subparagraph is information concerning the following:
(ii) How any formulary (including any tiered formulary structure) used by the sponsor functions, including a description of how a part D eligible individual may obtain information on the formulary consistent with paragraph (3).
(iii) Beneficiary cost-sharing requirements and how a part D eligible individual may obtain information on such requirements, including tiered or other copayment level applicable to each drug (or class of drugs), consistent with paragraph (3).
(2) Disclosure upon request of general coverage, utilization, and grievance information
Upon request of a part D eligible individual who is eligible to enroll in a prescription drug plan, the PDP sponsor offering such plan shall provide information similar (as determined by the Secretary) to the information described in subparagraphs (A), (B), and (C) of section 1395w–22 (c)(2) of this title to such individual.
(3) Provision of specific information
(A) Response to beneficiary questions
Each PDP sponsor offering a prescription drug plan shall have a mechanism for providing specific information on a timely basis to enrollees upon request. Such mechanism shall include access to information through the use of a toll-free telephone number and, upon request, the provision of such information in writing.
(B) Availability of information on changes in formulary through the Internet
A PDP sponsor offering a prescription drug plan shall make available on a timely basis through an Internet website information on specific changes in the formulary under the plan (including changes to tiered or preferred status of covered part D drugs).
(4) Claims information
A PDP sponsor offering a prescription drug plan must furnish to each enrollee in a form easily understandable to such enrollees—
(A) an explanation of benefits (in accordance with section 1395b–7 (a) of this title or in a comparable manner); and
(B) when prescription drug benefits are provided under this part, a notice of the benefits in relation to—
(b) Access to covered part D drugs
(1) Assuring pharmacy access
(A) Participation of any willing pharmacy
A prescription drug plan shall permit the participation of any pharmacy that meets the terms and conditions under the plan.
(B) Discounts allowed for network pharmacies
For covered part D drugs dispensed through in-network pharmacies, a prescription drug plan may, notwithstanding subparagraph (A), reduce coinsurance or copayments for part D eligible individuals enrolled in the plan below the level otherwise required. In no case shall such a reduction result in an increase in payments made by the Secretary under section 1395w–115 of this title to a plan.
(C) Convenient access for network pharmacies
(i) In general The PDP sponsor of the prescription drug plan shall secure the participation in its network of a sufficient number of pharmacies that dispense (other than by mail order) drugs directly to patients to ensure convenient access (consistent with rules established by the Secretary).
(ii) Application of TRICARE standards The Secretary shall establish rules for convenient access to in-network pharmacies under this subparagraph that are no less favorable to enrollees than the rules for convenient access to pharmacies included in the statement of work of solicitation (#MDA906–03–R–0002) of the Department of Defense under the TRICARE Retail Pharmacy (TRRx) as of March 13, 2003.
(iv) Convenient access in long-term care facilities Such rules may include standards with respect to access for enrollees who are residing in long-term care facilities and for pharmacies operated by the Indian Health Service, Indian tribes and tribal organizations, and urban Indian organizations (as defined in section 1603 of title 25).
(D) Level playing field
Such a sponsor shall permit enrollees to receive benefits (which may include a 90-day supply of drugs or biologicals) through a pharmacy (other than a mail order pharmacy), with any differential in charge paid by such enrollees.
(2) Use of standardized technology
(A) In general
(B) Standards
(i) In general The Secretary shall provide for the development, adoption, or recognition of standards relating to a standardized format for the card or other technology required under subparagraph (A). Such standards shall be compatible with part C of subchapter XI of this chapter and may be based on standards developed by an appropriate standard setting organization.
(ii) Consultation In developing the standards under clause (i), the Secretary shall consult with the National Council for Prescription Drug Programs and other standard setting organizations determined appropriate by the Secretary.
(3) Requirements on development and application of formularies
If a PDP sponsor of a prescription drug plan uses a formulary (including the use of tiered cost-sharing), the following requirements must be met:
(A) Development and revision by a pharmacy and therapeutic (P&T) committee
(i) In general The formulary must be developed and reviewed by a pharmacy and therapeutic committee. A majority of the members of such committee shall consist of individuals who are practicing physicians or practicing pharmacists (or both).
(B) Formulary development
In developing and reviewing the formulary, the committee shall—
(i) base clinical decisions on the strength of scientific evidence and standards of practice, including assessing peer-reviewed medical literature, such as randomized clinical trials, pharmacoeconomic studies, outcomes research data, and on such other information as the committee determines to be appropriate; and
(C) Inclusion of drugs in all therapeutic categories and classes
(i) In general Subject to subparagraph (G), the formulary must include drugs within each therapeutic category and class of covered part D drugs, although not necessarily all drugs within such categories and classes.
(ii) Model guidelines The Secretary shall request the United States Pharmacopeia to develop, in consultation with pharmaceutical benefit managers and other interested parties, a list of categories and classes that may be used by prescription drug plans under this paragraph and to revise such classification from time to time to reflect changes in therapeutic uses of covered part D drugs and the additions of new covered part D drugs.
(iii) Limitation on changes in therapeutic classification The PDP sponsor of a prescription drug plan may not change the therapeutic categories and classes in a formulary other than at the beginning of each plan year except as the Secretary may permit to take into account new therapeutic uses and newly approved covered part D drugs.
(D) Provider and patient education
The PDP sponsor shall establish policies and procedures to educate and inform health care providers and enrollees concerning the formulary.
(E) Notice before removing drug from formulary or changing preferred or tier status of drug
Any removal of a covered part D drug from a formulary and any change in the preferred or tiered cost-sharing status of such a drug shall take effect only after appropriate notice is made available (such as under subsection (a)(3) of this section) to the Secretary, affected enrollees, physicians, pharmacies, and pharmacists.
(F) Periodic evaluation of protocols
In connection with the formulary, the sponsor of a prescription drug plan shall provide for the periodic evaluation and analysis of treatment protocols and procedures.
(G) Required inclusion of drugs in certain categories and classes
(i) Formulary requirements
(I) In general Subject to subclause (II), a PDP sponsor offering a prescription drug plan shall be required to include all covered part D drugs in the categories and classes identified by the Secretary under clause (ii)(I).
(II) Exceptions The Secretary may establish exceptions that permit a PDP sponsor offering a prescription drug plan to exclude from its formulary a particular covered part D drug in a category or class that is otherwise required to be included in the formulary under subclause (I) (or to otherwise limit access to such a drug, including through prior authorization or utilization management).
(ii) Identification of drugs in certain categories and classes
(I) In general Subject to clause (iv), the Secretary shall identify, as appropriate, categories and classes of drugs for which the Secretary determines are of clinical concern.
(iii) Implementation The Secretary shall establish the criteria under clause (ii)(II) and any exceptions under clause (i)(II) through the promulgation of a regulation which includes a public notice and comment period.
(iv) Requirement for certain categories and classes until criteria established Until such time as the Secretary establishes the criteria under clause (ii)(II) the following categories and classes of drugs shall be identified under clause (ii)(I):
(H) Use of single, uniform exceptions and appeals process
Notwithstanding any other provision of this part, each PDP sponsor of a prescription drug plan shall—
(i) use a single, uniform exceptions and appeals process (including, to the extent the Secretary determines feasible, a single, uniform model form for use under such process) with respect to the determination of prescription drug coverage for an enrollee under the plan; and
(c) Cost and utilization management; quality assurance; medication therapy management program
(1) In general
The PDP sponsor shall have in place, directly or through appropriate arrangements, with respect to covered part D drugs, the following:
(A) A cost-effective drug utilization management program, including incentives to reduce costs when medically appropriate, such as through the use of multiple source drugs (as defined in section 1396r–8 (k)(7)(A)(i) of this title).
(B) Quality assurance measures and systems to reduce medication errors and adverse drug interactions and improve medication use.
Nothing in this section shall be construed as impairing a PDP sponsor from utilizing cost management tools (including differential payments) under all methods of operation.
(2) Medication therapy management program
(A) Description
(i) In general A medication therapy management program described in this paragraph is a program of drug therapy management that may be furnished by a pharmacist and that is designed to assure, with respect to targeted beneficiaries described in clause (ii), that covered part D drugs under the prescription drug plan are appropriately used to optimize therapeutic outcomes through improved medication use, and to reduce the risk of adverse events, including adverse drug interactions. Such a program may distinguish between services in ambulatory and institutional settings.
(ii) Targeted beneficiaries described Targeted beneficiaries described in this clause are part D eligible individuals who—
(I) have multiple chronic diseases (such as diabetes, asthma, hypertension, hyperlipidemia, and congestive heart failure);
(B) Elements
Such program may include elements that promote—
(i) enhanced enrollee understanding to promote the appropriate use of medications by enrollees and to reduce the risk of potential adverse events associated with medications, through beneficiary education, counseling, and other appropriate means;
(ii) increased enrollee adherence with prescription medication regimens through medication refill reminders, special packaging, and other compliance programs and other appropriate means; and
(C) Required interventions
For plan years beginning on or after the date that is 2 years after March 23, 2010, prescription drug plan sponsors shall offer medication therapy management services to targeted beneficiaries described in subparagraph (A)(ii) that include, at a minimum, the following to increase adherence to prescription medications or other goals deemed necessary by the Secretary:
(i) An annual comprehensive medication review furnished person-to-person or using telehealth technologies (as defined by the Secretary) by a licensed pharmacist or other qualified provider. The comprehensive medication review—
(I) shall include a review of the individual's medications and may result in the creation of a recommended medication action plan or other actions in consultation with the individual and with input from the prescriber to the extent necessary and practicable; and
(II) shall include providing the individual with a written or printed summary of the results of the review.The Secretary, in consultation with relevant stakeholders, shall develop a standardized format for the action plan under subclause (I) and the summary under subclause (II).
(D) Assessment
The prescription drug plan sponsor shall have in place a process to assess, at least on a quarterly basis, the medication use of individuals who are at risk but not enrolled in the medication therapy management program, including individuals who have experienced a transition in care, if the prescription drug plan sponsor has access to that information.
(E) 1 Automatic enrollment with ability to opt-out
The prescription drug plan sponsor shall have in place a process to—
(i) subject to clause (ii), automatically enroll targeted beneficiaries described in subparagraph (A)(ii), including beneficiaries identified under subparagraph (D), in the medication therapy management program required under this subsection; and
(E) 1 Development of program in cooperation with licensed pharmacists
Such program shall be developed in cooperation with licensed and practicing pharmacists and physicians.
(F) Coordination with care management plans
The Secretary shall establish guidelines for the coordination of any medication therapy management program under this paragraph with respect to a targeted beneficiary with any care management plan established with respect to such beneficiary under a chronic care improvement program under section 1395b–8 of this title.
(G) Considerations in pharmacy fees
The PDP sponsor of a prescription drug plan shall take into account, in establishing fees for pharmacists and others providing services under such plan, the resources used, and time required to, implement the medication therapy management program under this paragraph. Each such sponsor shall disclose to the Secretary upon request the amount of any such management or dispensing fees. The provisions of section 1396r–8 (b)(3)(D) of this title apply to information disclosed under this subparagraph.
(3) Reducing wasteful dispensing of outpatient prescription drugs in long-term care facilities
The Secretary shall require PDP sponsors of prescription drug plans to utilize specific, uniform dispensing techniques, as determined by the Secretary, in consultation with relevant stakeholders (including representatives of nursing facilities, residents of nursing facilities, pharmacists, the pharmacy industry (including retail and long-term care pharmacy), prescription drug plans, MA–PD plans, and any other stakeholders the Secretary determines appropriate), such as weekly, daily, or automated dose dispensing, when dispensing covered part D drugs to enrollees who reside in a long-term care facility in order to reduce waste associated with 30-day fills.
(d) Consumer satisfaction surveys
In order to provide for comparative information under section 1395w–101 (c)(3)(A)(v) of this title, the Secretary shall conduct consumer satisfaction surveys with respect to PDP sponsors and prescription drug plans in a manner similar to the manner such surveys are conducted for MA organizations and MA plans under part C of this subchapter.
(e) Electronic prescription program
(1) Application of standards
As of such date as the Secretary may specify, but not later than 1 year after the date of promulgation of final standards under paragraph (4)(D), prescriptions and other information described in paragraph (2)(A) for covered part D drugs prescribed for part D eligible individuals that are transmitted electronically shall be transmitted only in accordance with such standards under an electronic prescription drug program that meets the requirements of paragraph (2).
(2) Program requirements
Consistent with uniform standards established under paragraph (3)—
(A) Provision of information to prescribing health care professional and dispensing pharmacies and pharmacists
An electronic prescription drug program shall provide for the electronic transmittal to the prescribing health care professional and to the dispensing pharmacy and pharmacist of the prescription and information on eligibility and benefits (including the drugs included in the applicable formulary, any tiered formulary structure, and any requirements for prior authorization) and of the following information with respect to the prescribing and dispensing of a covered part D drug:
(i) Information on the drug being prescribed or dispensed and other drugs listed on the medication history, including information on drug-drug interactions, warnings or cautions, and, when indicated, dosage adjustments.
(B) Application to medical history information
Effective on and after such date as the Secretary specifies and after the establishment of appropriate standards to carry out this subparagraph, the program shall provide for the electronic transmittal in a manner similar to the manner under subparagraph (A) of information that relates to the medical history concerning the individual and related to a covered part D drug being prescribed or dispensed, upon request of the professional or pharmacist involved.
(C) Limitations
Information shall only be disclosed under subparagraph (A) or (B) if the disclosure of such information is permitted under the Federal regulations (concerning the privacy of individually identifiable health information) promulgated under section 264(c) of the Health Insurance Portability and Accountability Act of 1996.
(3) Standards
(A) In general
The Secretary shall provide consistent with this subsection for the promulgation of uniform standards relating to the requirements for electronic prescription drug programs under paragraph (2).
(B) Objectives
Such standards shall be consistent with the objectives of improving—
(C) Design criteria
Such standards shall—
(i) be designed so that, to the extent practicable, the standards do not impose an undue administrative burden on prescribing health care professionals and dispensing pharmacies and pharmacists;
(ii) be compatible with standards established under part C of subchapter XI of this chapter, standards established under subsection (b)(2)(B)(i) of this section, and with general health information technology standards; and
(D) Permitting use of appropriate messaging
Such standards shall allow for the messaging of information only if it relates to the appropriate prescribing of drugs, including quality assurance measures and systems referred to in subsection (c)(1)(B) of this section.
(E) Permitting patient designation of dispensing pharmacy
(i) In general Consistent with clause (ii), such standards shall permit a part D eligible individual to designate a particular pharmacy to dispense a prescribed drug.
(4) Development, promulgation, and modification of standards
(A) Initial standards
Not later than September 1, 2005, the Secretary shall develop, adopt, recognize, or modify initial uniform standards relating to the requirements for electronic prescription drug programs described in paragraph (2) taking into consideration the recommendations (if any) from the National Committee on Vital and Health Statistics (as established under section 242k (k) of this title) under subparagraph (B).
(B) Role of NCVHS
The National Committee on Vital and Health Statistics shall develop recommendations for uniform standards relating to such requirements in consultation with the following:
(C) Pilot project to test initial standards
(i) In general During the 1-year period that begins on January 1, 2006, the Secretary shall conduct a pilot project to test the initial standards developed under subparagraph (A) prior to the promulgation of the final uniform standards under subparagraph (D) in order to provide for the efficient implementation of the requirements described in paragraph (2).
(ii) Exception Pilot testing of standards is not required under clause (i) where there already is adequate industry experience with such standards, as determined by the Secretary after consultation with effected standard setting organizations and industry users.
(iii) Voluntary participation of physicians and pharmacies In order to conduct the pilot project under clause (i), the Secretary shall enter into agreements with physicians, physician groups, pharmacies, hospitals, PDP sponsors, MA organizations, and other appropriate entities under which health care professionals electronically transmit prescriptions to dispensing pharmacies and pharmacists in accordance with such standards.
(5) Relation to State laws
The standards promulgated under this subsection shall supersede any State law or regulation that—
(6) Establishment of safe harbor
The Secretary, in consultation with the Attorney General, shall promulgate regulations that provide for a safe harbor from sanctions under paragraphs (1) and (2) of section 1320a–7b (b) of this title and an exception to the prohibition under subsection (a)(1) ofsection 1395nn of this title with respect to the provision of nonmonetary remuneration (in the form of hardware, software, or information technology and training services) necessary and used solely to receive and transmit electronic prescription information in accordance with the standards promulgated under this subsection—
(B) in the case of a group practice (as defined in section 1395nn (h)(4) of this title), by the practice to prescribing health care professionals who are members of such practice; and
(f) Grievance mechanism
Each PDP sponsor shall provide meaningful procedures for hearing and resolving grievances between the sponsor (including any entity or individual through which the sponsor provides covered benefits) and enrollees with prescription drug plans of the sponsor under this part in accordance with section 1395w–22 (f) of this title.
(g) Coverage determinations and reconsiderations
(1) Application of coverage determination and reconsideration provisions
A PDP sponsor shall meet the requirements of paragraphs (1) through (3) of section 1395w–22 (g) of this title with respect to covered benefits under the prescription drug plan it offers under this part in the same manner as such requirements apply to an MA organization with respect to benefits it offers under an MA plan under part C of this subchapter.
(2) Request for a determination for the treatment of tiered formulary drug
In the case of a prescription drug plan offered by a PDP sponsor that provides for tiered cost-sharing for drugs included within a formulary and provides lower cost-sharing for preferred drugs included within the formulary, a part D eligible individual who is enrolled in the plan may request an exception to the tiered cost-sharing structure. Under such an exception, a nonpreferred drug could be covered under the terms applicable for preferred drugs if the prescribing physician determines that the preferred drug for treatment of the same condition either would not be as effective for the individual or would have adverse effects for the individual or both. A PDP sponsor shall have an exceptions process under this paragraph consistent with guidelines established by the Secretary for making a determination with respect to such a request. Denial of such an exception shall be treated as a coverage denial for purposes of applying subsection (h) of this section.
(h) Appeals
(1) In general
Subject to paragraph (2), a PDP sponsor shall meet the requirements of paragraphs (4) and (5) of section 1395w–22 (g) of this title with respect to benefits (including a determination related to the application of tiered cost-sharing described in subsection (g)(2) of this section) in a manner similar (as determined by the Secretary) to the manner such requirements apply to an MA organization with respect to benefits under the original medicare fee-for-service program option it offers under an MA plan under part C of this subchapter. In applying this paragraph only the part D eligible individual shall be entitled to bring such an appeal.
(2) Limitation in cases on nonformulary determinations
A part D eligible individual who is enrolled in a prescription drug plan offered by a PDP sponsor may appeal under paragraph (1) a determination not to provide for coverage of a covered part D drug that is not on the formulary under the plan only if the prescribing physician determines that all covered part D drugs on any tier of the formulary for treatment of the same condition would not be as effective for the individual as the nonformulary drug, would have adverse effects for the individual, or both.
(3) Treatment of nonformulary determinations
If a PDP sponsor determines that a plan provides coverage for a covered part D drug that is not on the formulary of the plan, the drug shall be treated as being included on the formulary for purposes of section 1395w–102 (b)(4)(C)(i) of this title.
(i) Privacy, confidentiality, and accuracy of enrollee records
(j) Treatment of accreditation
Subparagraph (A) of section 1395w–22 (e)(4) of this title (relating to treatment of accreditation) shall apply to a PDP sponsor under this part with respect to the following requirements, in the same manner as it applies to an MA organization with respect to the requirements in subparagraph (B) (other than clause (vii) thereof) of such section:
(k) Public disclosure of pharmaceutical prices for equivalent drugs
(1) In general
A PDP sponsor offering a prescription drug plan shall provide that each pharmacy that dispenses a covered part D drug shall inform an enrollee of any differential between the price of the drug to the enrollee and the price of the lowest priced generic covered part D drug under the plan that is therapeutically equivalent and bioequivalent and available at such pharmacy.
(2) Timing of notice
(A) In general
Subject to subparagraph (B), the information under paragraph (1) shall be provided at the time of purchase of the drug involved, or, in the case of dispensing by mail order, at the time of delivery of such drug.
(l) Requirements with respect to sales and marketing activities
The following provisions shall apply to a PDP sponsor (and the agents, brokers, and other third parties representing such sponsor) in the same manner as such provisions apply to a Medicare Advantage organization (and the agents, brokers, and other third parties representing such organization):
(1) The prohibition under section 1395w–21 (h)(4)(C) of this title on conducting activities described in section 1395w–21 (j)(1) of this title.
(2) The requirement under section 1395w–21 (h)(4)(D) of this title to conduct activities described in section 1395w–21 (j)(2) of this title in accordance with the limitations established under such subsection.
[1] So in original. Two subpars. (E) have been enacted.
[2] So in original. Probably should be followed by a period.
Source(Aug. 14, 1935, ch. 531, title XVIII, § 1860D–4, as added Pub. L. 108–173, title I, § 101(a)(2),Dec. 8, 2003, 117 Stat. 2082; amended Pub. L. 110–275, title I, §§ 103(a)(2), (b)(2), (c)(2), (d)(2), 176,July 15, 2008, 122 Stat. 2499–2501, 2581; Pub. L. 111–148, title III, §§ 3307(a), 3310 (a), 3312 (a), title X, § 10328(a),Mar. 23, 2010, 124 Stat. 471, 475, 476, 964.)
References in Text
Section 264(c) of the Health Insurance Portability and Accountability Act of 1996, referred to in subsec. (e)(2)(C), is section 264(c) ofPub. L. 104–191, which is set out as a note under section 1320d–2 of this title.
2010—Subsec. (b)(3)(G). Pub. L. 111–148, § 3307(a), amended subpar. (G) generally. Prior to amendment, subpar. (G) related to required inclusion of drugs in certain categories and classes.
Subsec. (b)(3)(H). Pub. L. 111–148, § 3312(a), added subpar. (H).
Subsec. (c)(2)(C) to (G). Pub. L. 111–148, § 10328(a), added subpars. (C) to (E) and redesignated former subpars. (C) to(E) as (E) to (G), respectively.
Subsec. (c)(3). Pub. L. 111–148, § 3310(a), added par. (3).
2008—Subsec. (b)(3)(C)(i). Pub. L. 110–275, § 176(1), substituted "Subject to subparagraph (G), the formulary" for "The formulary".
Subsec. (b)(3)(G). Pub. L. 110–275, § 176(2), added subpar. (G).
Subsec. (l). Pub. L. 110–275, § 103(a)(2), added subsec. (l).
Subsec. (l)(2). Pub. L. 110–275, § 103(b)(2), added par. (2).
Subsec. (l)(3). Pub. L. 110–275, § 103(c)(2), added par. (3).
Subsec. (l)(4). Pub. L. 110–275, § 103(d)(2), added par. (4).
Effective Date of 2010 Amendment
Pub. L. 111–148, title III, § 3307(b),Mar. 23, 2010, 124 Stat. 472, provided that: "The amendments made by this section [amending this section] shall apply to plan year 2011 and subsequent plan years."
Pub. L. 111–148, title III, § 3310(b),Mar. 23, 2010, 124 Stat. 475, provided that: "The amendment made by subsection (a) [amending this section] shall apply to plan years beginning on or after January 1, 2012."
Pub. L. 111–148, title III, § 3312(b),Mar. 23, 2010, 124 Stat. 476, provided that: "The amendment made by subsection (a) [amending this section] shall apply to exceptions and appeals on or after January 1, 2012."
Effective Date of 2008 Amendment
Amendment by section 103(a)(2) ofPub. L. 110–275applicable to plan years beginning on or after Jan. 1, 2009, see section 103(a)(3) ofPub. L. 110–275, set out as a note under section 1395w–21 of this title.
Amendment by section 103(b)(2) ofPub. L. 110–275effective on a date specified by the Secretary (but in no case later than Nov. 15, 2008), see section 103(b)(3) ofPub. L. 110–275, set out as a note under section 1395w–21 of this title.
Amendment by section 103(d)(2) ofPub. L. 110–275applicable to plan years beginning on or after Jan. 1, 2009, see section 103(d)(3) ofPub. L. 110–275, set out as a note under section 1395w–21 of this title.
Rule of Construction
Pub. L. 111–148, title X, § 10328(b),Mar. 23, 2010, 124 Stat. 965, provided that: "Nothing in this section [amending this section] shall limit the authority of the Secretary of Health and Human Services to modify or broaden requirements for a medication therapy management program under part D of title XVIII of the Social Security Act [42 U.S.C. 1395w–101 et seq.] or to study new models for medication therapy management through the Center for Medicare and Medicaid Innovation under section 1115A of such Act [42 U.S.C. 1315a], as added by section 3021 [of Pub. L. 111–148]."
Grants to Physicians To Implement Electronic Prescription Drug Programs
Pub. L. 108–173, title I, § 108,Dec. 8, 2003, 117 Stat. 2172, provided that:
"(a) In General.—The Secretary [of Health and Human Services] is authorized to make grants to physicians for the purpose of assisting such physicians to implement electronic prescription drug programs that comply with the standards promulgated or modified under section 1860D–4(e) of the Social Security Act [42 U.S.C. 1395w–104 (e)], as inserted by section 101 (a).
"(b) Awarding of Grants.—
"(1) Application.—No grant may be made under this section except pursuant to a grant application that is submitted and approved in a time, manner, and form specified by the Secretary.
"(2) Considerations and preferences.—In awarding grants under this section, the Secretary shall—
"(A) give special consideration to physicians who serve a disproportionate number of medicare patients; and
"(B) give preference to physicians who serve a rural or underserved area.
"(3) Limitation on grants.—Only 1 grant may be awarded under this section with respect to any physician or group practice of physicians.
"(c) Terms and Conditions.—
"(1) In general.—Grants under this section shall be made under such terms and conditions as the Secretary specifies consistent with this section.
"(2) Use of grant funds.—Funds provided under grants under this section may be used for any of the following:
"(A) For purchasing, leasing, and installing computer software and hardware, including handheld computer technologies.
"(B) Making upgrades and other improvements to existing computer software and hardware to enable e-prescribing.
"(C) Providing education and training to eligible physician staff on the use of technology to implement the electronic transmission of prescription and patient information.
"(3) Provision of information.—As a condition for the awarding of a grant under this section, an applicant shall provide to the Secretary such information as the Secretary may require in order to—
"(A) evaluate the project for which the grant is made; and
"(B) ensure that funding provided under the grant is expended only for the purposes for which it is made.
"(4) Audit.—The Secretary shall conduct appropriate audits of grants under this section.
"(5) Matching requirement.—The applicant for a grant under this section shall agree, with respect to the costs to be incurred by the applicant in implementing an electronic prescription drug program, to make available (directly or through donations from public or private entities) non-Federal contributions toward such costs in an amount that is not less than 50 percent of such costs. Non-Federal contributions under the previous sentence may be in cash or in kind, fairly evaluated, including plant, equipment, or services. Amounts provided by the Federal Government, or services assisted or subsidized to any significant extent by the Federal Government, may not be included in determining the amount of such contributions.
"(d) Authorization of Appropriations.—There are authorized to be appropriated to carry out this section $50,000,000 for fiscal year 2007 and such sums as may be necessary for each of fiscal years 2008 and 2009."
LII has no control over and does not endorse any external Internet site that contains links to or references LII.


text:
Fashion Films
Project Archive
Sign In | Register
Follow us
The Home of Fashion Film and Live Fashion Broadcasting
Shop Fashion
Shop Art
Fashion Films
Project Archive
Follow us
Recently Updated
Alphabetical A - Z
Alphabetical Z - A
Fashion Films
Guest Reports
Contemporary Art
Video Art
Behind The Scenes
Video Portraits
Paris Collections
Fashion Shoots
Nick Knight and Jane How
Nov 10 2000
Here's something we made earlier: stylist Jane How recreated her favourite looks of Spring/Summer 2000 from sweet papers, cupcake wrappers and doilies,...
Nick Knight, Katy England and Alice Rawsthorn
One In Ten
Nov 17 2000
If breast cancer affects one-in-ten women, why is it invisible in fashion photography? Nick Knight and stylist Katy England redressed the balance in a ...
Nick Knight, Kate Moss, Sarah Morris and Emily Dinsdale
Dec 20 2000
Follow Nick Knight's lens as it snoops from one Madison Avenue skyscraper to another, documenting supermodel Kate Moss in voyeuristic action in this un...
Nick Knight and Camille Bidault Waddington
Dec 20 2000
Take a model styled by Camille Bidault Waddington with hair by Sam McKnight. Let a four year-old, a one year-old and two three year-olds do what ever t...
Nick Knight, Jane How and Lone Sigurdsson
Feb 9 2001
A unique interpretation of the Spring/Summer 2000 collections, Lone Sigurdsson worked with stylist Jane How to create plasticine replicas of the season...
Nick Knight and Adam Mufti
Nov 6 2001
Jerry Springer, beauty queens, a '57 Cadillac, 'Gummo', Angela Lindvall and lots of spray paint. Put them in a blender and what did you get? This fashi...
Nick Knight, Hussein Chalayan, Terry Richardson, Richard Bush, Raf Simons, Jo-Ann Furniss, Tim Walker, Penny Martin, John Taylor, Jane How and David Sims
Jan 23 2002
Focusing on fashion imagery published and withdrawn at the time of the attacks of 9/11, Killed examines the criteria governing propriety in contemporar...
Nick Knight and John Galliano
Past, Present & Couture
Mar 2 2002
John Galliano's first five years at Christian Dior were marked by a series of Nick Knight-shot images interpreting Galliano's groundbreaking haute cout...
Nick Knight
More Beautiful Women
Jun 13 2002
An homage to Andy Warhol's screen tests, 'More Beautiful Women' evolved from Nick Knight's commission to photograph the most famous models of the twent...
Nick Knight and Steve Beale
Come As You Are
Dec 6 2002
Celebrate ten years of imagery from the pages of Dazed through your own interactive photo-montage.
Nick Knight, Jonathan Kaye and Akufen
Jun 5 2003
Contextualising the Spring/Summer 2003 haute couture collections as photographed for W magazine, 'SHOOT' proves that couture is far more than just dres...
Jane How
Pop Poupée
Aug 4 2003
Taking inspiration from Andy Warhol - the man(nequin) himself even making a cameo as a model - stylist Jane How and photographer Mario Sorrenti recreat...
John Galliano
Galliano Hommes
Oct 24 2003
Exclusive preview of Galliano's first own-brand menswear range for A/W 04. The legendary designer took questions from the set of his Arena shoot.
Nick Knight, Simon Foxton, Jonathan Kaye, Gemma Ward and Penny Martin
By Arrangement
Nov 27 2003
Evangelical florist and icon of pre-war femininity, Constance Spry provided inspiration for this three day Nick Knight shoot for W magazine. Stylist Jo...
Nick Knight, Val Garland, Sam McKnight, Gemma Ward, Lily Cole, Penny Martin and Marian Newman
Jan 16 2004
Nick Knight's stalwart hair and make-up team threw open their studio doors during a three-day collections shoot for British Vogue's April 2004 issue. D...
Simon Foxton and Jason Evans
Fancy Pants
Feb 2 2004
In January 2004, photographer Jason Evans and stylist Simon Foxton played a game of chance with an i-D menswear editorial. Eschewing the comfort of pre...
Ebru Ercon and Penny Martin
Lookbook: Ebru Ercon
Apr 5 2004
Fresh from a stellar appearance at cult showcase Fashion East, designer Ebru Ercon came into the SHOWstudio live space to photograph her look book, enl...
Nick Knight, Val Garland, Sam McKnight, Rei Kawakubo, Erin O'Connor, Allan Finamore and Alister Mackie
Power Of Witches
May 28 2004
Developed in collaboration with Rei Kawakubo of Comme des Garçons, 'Power of Witches' lays bare every step in the creation of a fashion image, showing ...
Nick Knight and Gemma Ward
Jun 7 2004
Kate Phelan and the Vogue team enter the SHOWstudio live space for three days to shoot the prevailing themes from the Autumn/Winter 2004 collections fo...
Alexander McQueen, Nick Knight and Michael Clark
Blade of Light
Jul 30 2004
Watch the filmic version of SHOWstudio's MAC III print, an image born out of an explosive creative collaboration between McQueen, Knight and Clark.
Simon Foxton and Paul Hunwick
Aug 17 2004
Profiling the early-noughties London club night Matinée, and its conspicuously fashionable attendees - dubbed 'Glitterbugs' - through images, text and...
Nick Knight, Peter Saville, Liberty Ross, Richard Kern, Philippe Garner, Jonathan Kaye, Jonathan De Villiers, Ann-Sofie Back and Andrea Dworkin
Dress Me Up, Dress Me Down
Jun 28 2005
Exploring the idea of control in fashion image-making, 'Dress Me Up, Dress Me Down' offered SHOWstudio viewers the chance to dress Liberty Ross in a li...
Junya Watanabe
Design Download: Junya Watanabe
Jun 28 2005
Internationally-acclaimed designer Junya Watanabe was the mastermind behind the fifth pattern offered as part of our Design Download series of online c...
Nick Knight, Nicola Formichetti, Val Garland, Sam McKnight, Tal Brener, Sarah Richardson, NOKI, Nancy Rohde, Katy England, Katie Grand, Jamie Surman, Jacob K, Francesca Burns, Ann-Sofie Back, Alister Mackie, Erin O'Connor and Marian Newman
Bring & Buy
Jul 7 2005
Patti Smith, Yoko Ono, Tilda Swinton and Björk - these were just some of the names that donated clothes to SHOWstudio's 'Bring & Buy' in July 2005. All...
Nick Knight, Susannah Frankel, Nick Ryan and Daniel Brown
The Sound Of Clothes: Synaesthesia
Apr 4 2006
Using the notion of 'pictures for the blind' as a stimulus, Nick Knight and digital artist Daniel Brown collaborated with synaesthete and sound designe...
Nick Knight, John Galliano, Ruth Hogben and Simon Foxton
Feb 20 2007
Invited by Arena Homme Plus magazine to photograph the highlights of John Galliano's outlandish Autumn/Winter 2007-2008 collection, Nick Knight and Sim...
Nick Knight, Ruth Hogben and Lily Donaldson
Ice Cream
Mar 9 2007
Captured during Nick Knight's shoot for 2006's Visionaire 49, the 'Decades' issue, 'Ice Cream' features unique pieces from the impressive Maison Martin...
Nick Knight, Naomi Campbell and Jonathan Kaye
Jul 26 2007
In January 2007, Nick Knight shot Naomi Campbell wearing the latest Paris haute couture for the summer issue of V magazine. Here we publish an online p...
Nick Knight, Shaun Cole and Alister Mackie
Sep 27 2007
Invited by AnOther Man magazine to shoot men's underwear for its Autumn/Winter 2007 issue, Nick Knight and Alister Mackie shot new work by a range of d...
Nick Knight, Ruth Hogben, Hussein Chalayan and Antony Hegarty
Oct 22 2007
Shown as part of Paris Fashion Week in October 2007 - in place of a traditional catwalk show - to present Hussein Chalayan's Spring/Summer 2008 collect...
Nick Knight, Ruth Hogben, Stefano Pilati, Jessica Miller and Gideon Ponte
Oct 25 2007
In July 2007, SHOWstudio offered viewers a unique chance to influence the narrative of a high-end fashion shoot, as Nick Knight collaborated with Stefa...
Kate Moss, Nick Knight, Ruth Hogben, Roddy Lumsden and Jonathan Kaye
Flowers For Kate
Nov 15 2007
Say it with flowers: In December 2007 Nick Knight photographed a story for the March/April 2008 issue of V magazine, featuring the one and only Kate Mo...
Nick Knight
Mar 7 2008
Filmed amidst the nuts-and-bolts of the photographic shoot, Showtime is a sneak preview of Nick Knight's editorial for the April 2008 edition of Britis...
Tony Ryan, Pinny Grylls, Patricia Belford, Kate Storey, Helen Storey and Alice Dellal
May 26 2008
Product of a groundbreaking collaboration between artist and fashion designer Helen Storey and scientist Tony Ryan, 'Wonderland' used fashion as a 'Tro...
Nick Knight, Ruth Hogben and Lily Donaldson
Nov 5 2008
Nick Knight's fashion film, Fantasia, is a free-wheeling exploration of joyous, unbridled movement in model and clothing alike. Harness to this the rio...
Nick Knight, Ruth Hogben, Gareth Pugh, Matthew Stone, Katie Shillingford and Alex Box
Nov 19 2008
Conjuring a macabre phantasmagoria that unfurls before your eyes like a sinister but beautiful bloom, Insensate showcases the brutal geometry and raw c...
Nick Knight, Ruth Hogben, Lily Donaldson, Sam McKnight, Val Garland and Jonathan Kaye
Let There Be Light
Jan 23 2009
Allowing unprecedented insight into a Nick Knight photo shoot, SHOWstudio shed light on every nitty-gritty detail as he works with model-of-the-moment ...
Nick Knight, Ruth Hogben and Lily Donaldson
Feb 4 2009
Featuring highly-strung fashions from Giorgio Armani, Louis Vuitton, Balenciaga and Alexander McQueen springing into vibrant life, 'Fringed' animates t...
Nick Knight, Ruth Hogben and Charlotte Stockdale
Black / White
Feb 26 2009
Incorporating the cream of Spring/Summer 2009's monochromatic fashions, Nick Knight and Ruth Hogben's fashion film was captured on set during Knight's ...
Nick Knight, Rick Owens and Panos Yiapanis
Rick Owens Portrait
Apr 9 2009
An intimate portrait of Rick Owens in his own words and his own clothing, this filmic diptych explores Nick Knight's monograph of an American fashion l...
Nick Knight, Peter Saville, Mariacarla Boscono, Gideon Ponte, Francesca Burns, Alana Zimmer, Raquel Couceiro and Lou Stoppard
Soft Furnishings
Apr 20 2009
As backdrop to an editorial story for July 2009 Wallpaper* magazine, Peter Saville's febrile imagination constructs an imaginary 'Erotic House' of Pop ...
Nick Knight, Liberty Ross and Katie Grand
Hart To Heart - When Tony Hart Met John Galliano
Jul 30 2009
Who better to capture and celebrate the innocent, unbridled joy of John Galliano's Autumn/Winter 2000 collection than the late Tony Hart? Recorded on s...
Nick Knight, Ruth Hogben, Gareth Pugh, Nicola Formichetti and Alex Box
Aug 11 2009
A blur of colour, reflection and frantic animation - with Gareth Pugh himself making more than a cameo appearance - this exclusive film edited by Ruth ...
Ruth Hogben, Gareth Pugh, Simon Costin, Matthew Stone and Katie Shillingford
Gareth Pugh S/S 2010
Sep 12 2009
In advance of the unveiling of his Spring/Summer 2010 collection in Paris, fashion designer Gareth Pugh collaborated once again with filmmaker Ruth Hog...
Nick Knight, Ruth Hogben, Panos Yiapanis and Carmen Kass
Oct 22 2009
Transforming Estonian übermodel Carmen Kass into a sinister high-fashion harlequin through photograph and moving image alike, a surreal and dreamlike v...
Nick Knight, Lady Gaga, Gareth Pugh, Ruth Hogben, Raquel Zimmermann, Val Garland, Sam McKnight and Marian Newman
Cutting Edge: Gareth Pugh
Jan 22 2010
Fashion designer Gareth Pugh creates a dress in the Live Studio. Edited from three days of live footage, this film documents the entire painstaking pro...
Nick Knight and Nicola Formichetti
Elegant Mechanics
Jun 25 2010
A collaboration between stylist Nicola Formichetti and Nick Knight to shoot a men's fashion editorial for Autumn/Winter 2010 Vogue Hommes Japan under t...
Naomi Campbell, Nick Knight, Lady Gaga, Riccardo Tisci, Princess Julia, Philip Start, Ollie Edwards, Milly McMahon, Matt Irwin, Luigi Murenu, Kirsten Owen, Katie Eary, Joe and Duke Brooks, House of Holland, Horse Meat Disco, Gwendoline Christie, Gemma Slack, Dominic Jones, Craig Lawrence, Chris Amfo-Okoampah, Carri Munden, Carrie Cassette Playa, Boy George, Bishi, Bella Freud, Behati Prinsloo, Anna Blessmann, Alice Dellal, Alex Box, Alana Zimmer, Lara Stone, Ash Stymest, Cole Mohr and David Gandy
200 Portraits
Aug 4 2010
To celebrate the 30th anniversary of i-D magazine, Nick Knight mirrored his 1985 '100 Portraits' series, photographing 200 culture icons.
Page 1 of 2
Previous page
Next page

subset: commoncrawl


text:
I have been a bad blogger lately and haven't posted at all this week!!
Sorry guys:(
I started back to school last Friday, and I have been trying to prepare myself for this semester,
and trying to get my nursery finished before my sweet girl comes!!!
My doctor set my C-section date for March 1!!!!
My first babyshower was a week ago, and it was so much fun!
I have this weird anxiety thing, and opening presents in front of people FREAKS me out.
It makes me so nervous, its the silliest thing!
To my advantage God decided to make my babyshower day a snow day!
It started snowing RIGHT when I started opening my presents, so after I would open someone's present they would leave so they could get home before the weather got bad!
This helped so much, Thank You Jesus!
This is my BEAUTIFUL cake that my best friend Christina got from Blue Cake Company in Little Rock, AR. They did such an awesome job! They even made it my favorite.. Italian Cream Cake:):)
Here is my cool diaper cake, Mrs. Mary and Nichole made!!
They did a great job!
This is my best friend Kelsea, she threw the shower!
She is explaining the diaper game haha she smashed 2 different candy bars in the diaper and everyone had to pass it around and guess what the candy bars were!
So this is a little blurry!
But I wanted all the moms to see this! It's a word scramble!!
Try to figure out some of those words, they were SO hard!
This is my beautiful best pregnant friend Kara:) She's due exactly 2 weeks after me!
Can you see what that bib says!? "Star of Mommy's Blog"
How funny is that!?!
Kinsley will definately be wearing that bib alot on this blog!
My next shower is this Saturday at my house so I have to go clean now:(
Hope you guys are having an awesome week!
I promise I'll try not to ever go this long without posting again:)


text:
The notebook as a tool for discovering a city. The international sketching community gets together again for a weekend of field sketching, lectures, exhibitions and workshops, this year in Barcelona, July 11-13th.
Moleskine notebooks have captured the Urban Sketching Symposium over the last three years, and this year the Urban Sketchers will use specially created, for the first time ever, Japanese Albums made with watercolour paper*. One unique sheet is folded into accordion pages, allowing the pencil to travel further, the watercolour ink to run across multiple pages; through contours and folds, bends and street corners. Each sketcher's story will unravel as the Album is opened. On the cover a debossing of the Urban Sketchers logo, the paperband decorated with four artist drawings.
If you aren't attending the Symposium, Fòrum Fnac Triangle is organising an open sketchathon to collect different perspectives and impressions around Barcelona. Participants will receive a Moleskine pocket sketchbook to fill with their sketches of the city and then return to the Sala Ciutat later that evening. A jury will pick a selection of notebooks for an exhibition in the days after the event. More info on the Facebook page here.
Moleskine Japanese Albums in use at myDetour 5x5 in Rome
And for those not in Barcelona. Every day during the Urban Sketching Symposium a sketch of one of the city's landmarks will be posted on the organization's Facebook and Twitter pages. Where was the sketch taken? Write your answer in the comments and a Moleskine Urban Sketchers Special Edition notebook could be yours.
For more info on Urban Sketchers visit the website.
*Cold pressed paper, 25% cotton fibre, 200 gsm


text:
Currently Shopping by
Shopping Options
- Category
- Software
- Business & Productivity
- Brand
- Microsoft (62)
- Nuance (1)
- SoftwareMedia (1)
Close Recently added item(s)
You have no items in your shopping cart.
Mon-Thurs 8am-5pm MDT
Friday 8am-4pm MDT
Currently Shopping by
Shopping Options
SoftwareMedia provides discount software to businesses & consumers and carries over 80 top software brands.
We offer a 100% satisfaction guarantee. If you have questions our knowledgeable staff can help find the best software solution for you.


text:
|START Conference Manager
ASIST 2012 Annual Meeting
Baltimore, MD, October 26-30, 2012
Tooling the Aggregator's Workbench: Metadata Visualization Through Statistical Text Analysis
Katrina Fenlon, Miles Efron and Peter Organisciak
Monday, 8:00am
Digital library interoperability efforts have succeeded in making large-scale aggregation of digital collections technically feasible. As silos are gradually dismantled and diverse digital collections are increasingly unified into aggregations, data heterogeneity presents growing challenges to aggregators. Comprehension of massive aggregates and efficient metadata quality analysis are aggregator imperatives that rely on scalable evaluation techniques. This paper describes novel applications of visualization techniques based on statistical text analysis to the evaluation and maintenance of a large-scale aggregation of descriptive, cultural heritage metadata. These techniques, and their implementation as part of an aggregator's workbench, provide new, administrator-oriented perspectives on metadata aggregations, in order to improve aggregators' capacity to evaluate metadata quality and topical coverage in a scalable way.


text:
Amateurtubed.com Review
This site features hot amateur girlfriends who love showing off for the camera and submit it for your viewing pleasure.
Tons of content:
The size of the site is really the best thing they have going for them. Once you get through everything, there are over 5,500 photo galleries and over 2,000 videos up currently. Those are some impressive numbers for sure, and you should be able to find something you like.
Large daily updates:
If you average out the updates for the last week, you'll find that they add around 4-5 new photo galleries per day, and at least one video per day as well. This is how they get their big numbers, so I guess it's pretty expected.
Official Site:


text:
Added to Cart
Extended Care Options
More deals you may like
Apple iPad Pro 9.7 (128GB, Cellular, Gold)
Refined design and amazingly smooth performance.
128GBSold out
With just a touch, swipe or jot, you can write, email, surf, scan, render, design, redesign and more. Simply put, iPad Pro puts incredible power that leaps past most portable PCs at your fingertips.
- 4G capable
- Double the graphics performance of iPad Air 2
- Breathtaking 9.7-inch display boasting up to 25 per cent greater colour saturation than previous iPad models
- Brilliant performance with the A9X chip that gives you the power to create in whole new ways
- 12-megapixel iSight camera captures stunning images with 50 per cent higher resolution than any other iPad
- Capture, edit and present seamlessly on one device
- Open, markup and design documents in Microsoft Office
- Writing on or marking up documents is as natural and quick as writing on a sheet of paper using the Apple Pencil
- Unbelievably thin and lightweight – weighing less than 500 grams
This Product is offered and supplied by Tandy Electronics pursuant to the Terms and Conditions.
Related CategoriesProjectorsAccess PointsThin / Zero ClientsMonitor AccessoriesAndroid TabletsNetworking & WirelessBluetooth SpeakersChromebooksDocument ScannerseBook ReadersOffice SuppliesNUC and PC StickRemote ControlsHandsets & Docks (Phones)Projector AccessoriesHeadsets/HeadphonesGraphics TabletsReplacement PartsToolsComputer SpeakersGaming ConsolesBags & CoversSwitchesKitchen AccessoriesComponents


text:
0 Members and 1 Guest are viewing this topic.
A Greek Orthodox priest once told me that "Christos Anesti," would be better translated as Christ has Risen. I don't know for sure.
Christ is Ascended!This phrase has always struck me as a bit awkward, and perhaps this is only because of my own grammatical deficiencies, but it still does.Does "ascend" simply lack a present tense in English, and is this why it seems so strange to me? It seems as though we should be saying either:"Christ is Ascending!"or"Christ has Ascended!"I suppose one could say the same of "Christ is Risen", that it should be "Christ has Risen" or "Christ is Rising", but for whatever reason the phrase "Christ is Risen" doesn't strike me as odd.Keep in mind that all of my sense of proper grammar is innate; that is to say that I am abysmal delineating syntax and sentence structure using official grammatical terminology. I just always rely on what "sounds right." So all of you English buffs help me out here!
English, like German of today, used to use "to be" as the auxilliary of intransitive verbs (ones that don't have objects, e.g. to fall, to go, to stand...) and "to have" for transitive ones (ones that have objects, e.g. to see, to hit, to take). Nothing more mysterious: if you go through the KJ you'll notice the usage.
Page created in 0.077 seconds with 24 queries.


text:
Breakfast Trends: New Ingredients Help Wake America Up
Substitute new ingredients to make 'the most important meal' even healthier.
The American breakfast table has changed dramatically since the Pilgrims landed and settled in Massachusetts in 1620. Rising early to begin their chores, our forefathers began the day with a spartan meal of cider and corn meal mush cooked over the embers all night, topped with maple sugar or molasses, according to the Oxford Encylopedia of Food and Drink in America.
Today we have a striking selection of breakfast choices, but most Americans pressed for time in the morning do not take advantage of this largesse. Many eat no breakfast at all, and others choose a quick breakfast of cereal, coffee and some fruit, according to one of the largest surveys ever conducted on breakfast and morning mealtime routine. Kellogg Co. (www.kelloggs.com), Battle Creek, Mich., surveyed more than 14,000 Americans of varying ethnicities, income levels, geographic regions and ages earlier this year and found that while the vast majority of Americans feel breakfast is important, the reality of hectic mornings makes it difficult to fit the meal in every day.
While more than half (54 percent) of all adults would like to eat breakfast every day, only one-third (34 percent) actually do; Nearly all moms (89 percent) want their kids to eat breakfast every day. However, 40 percent of moms report their children don't eat breakfast daily.
Nearly all toddlers and preschool-age children are eating breakfast; however, consumption of breakfast dips as American children grow older. 77 percent of young children eat breakfast every day, but the number falls to 50 percent in the middle-school years and 36 percent among high school students. Although moms report a desire to see their kids relax in the morning and concentrate on eating breakfast, many kids are too busy watching television, getting their homework done or getting ready for school to do so.
Agriculture Secretary Tom Vilsack marked National School Breakfast Week (March 7-12) by emphasizing the administration's commitment to provide school children with healthy, well-balanced meals to prepare them for a productive school day. Working with First Lady Michelle Obama's Let's Move! initiative, USDA is enhancing programs that will help to raise a healthier generation of students who will enter the classroom ready to concentrate, engage and learn.
"A nutritious breakfast will help our children learn better and have the energy needed for academic success," said Vilsack. "By ensuring all children have access to a healthy breakfast, we help lay the groundwork for a successful day and build a foundation for achievement that will help our kids win the future."
Join the discussion
We welcome your thoughtful comments.
All comments will display your user name.
Want to participate in the discussion?Register for free
Log in for complete access.
No one has commented on this page yet.
RSS feed for comments on this page | RSS feed for all comments


text:
Next Meetup
What we're about
Dear Friends,
The Humane Society of Louisiana offers a variety of volunteer opportunities that can easily fit into everyone's schedule. Our group was established in New Orleans 1988, and we have a long history of advocating for the protection of animals, whether it is in the classroom, the State Capitol or in the courtroom. Our group also operates a no-kill animal sanctuary located in Tylertown, Mississippi. To encourage a healthy plant-based diet and lifestyle, our group also started the New Orleans Vegetarian Society which has more than 500 members. For more information, please visit us at meetup.com, as well.
There are any number of ways to get involved as a volunteer. Here is just a partial list:
- join our investigations department. These volunteers respond to hundreds of complaints each year by visiting households or businesses where abuse may be taking place or by working with law enforcement officials to ensure that the animal protection laws are upheld. We also have volunteer caseworkers who monitor complaints, once they have been filed with our organization. These volunteers meet throughout the year.
- join our humane education department and become one of our pet care educators! These volunteers visit schools, YMCAs, nursing homes and other venues throughout the year, educating the young and old about the need to properly care for all animals.
- join our outreach team and help us man tables and booths at different festivals and events around town.
We also encourage you to join our group as a dues-pay member. Dues
are only $20.00 for individual or $35.00 for family. Checks may be sent
to the Humane Society of Louisiana, P.O. Box 740321, New Orleans, LA
70174 or make a donation online throughout our website at www.
Sincerely yours,
Jeff Dorson
Director, Humane Society of Louisiana


text:
Car Video
2012 Toyota Yaris: New Car Review - Video
Mike Hatton: The small-car market has been getting a lot of attention from automakers in recent years. With the Hyundai Accent, the Kia Rio and the Mazda2, the bar has been raised.
Amanda Salas: And to meet its growing competition, Toyota has released its second-generation Yaris. The Yaris itself has grown-literally: it's 2.9 inches longer and two inches wider.
Mike: But it's going to take more than just a boost in size to make the Yaris a winner, and the new styling is a great start. The old model had a more bulbous look, but the 2012 model is sharp and angular, proving that small doesn't have to be cute.
Amanda: The Yaris comes in L, LE and SE trims and is available in three- or five-door hatchback setups. A sedan was previously available but has been dropped for 2012.
Mike: The top-of-the-line SE is only available as a five-door and features 16-inch alloy wheels, fog lights and a spoiler above the rear hatch.
Amanda: But drivers spend more time in the car, not staring at it. That's where Toyota needs to step up its game to stay competitive.
Mike: The interior isn't bad; you get exactly what you need but not a lot more. Several years ago, this would have been a perfectly acceptable interior, but not with cars like the Kia Rio and Hyundai Accent on the market.
Amanda: I agree. And you don't get the kind of features that make a 40-minute commute more enjoyable, like heated seats and navigation, two of my personal favorites.
Mike: On the plus side, Toyota did beef up the sound deadening, which will make your commutes a little bit quieter-that is, until I crank up the premium stereo on the LE or SE models.
Amanda: The SE has a tighter, sport-tuned suspension and steering ratio. The result is actually fun handling.
Mike: Toyota carried over the 1.5-liter inline-4 from last year. It sends 106 horsepower to the front wheels through either a five-speed manual transmission or a four-speed automatic.
Amanda: With either transmission options, you'll get 30 miles per gallon city. With the manual you'll get 38 on the highway, but with the automatic you'll drop to 35.
Mike: Those fuel economy numbers can make you forget about the interior shortcomings, and so can the price. A base L three-door starts at just over $14,000, and a five-door SE with options will only set you back about $18,000. GFX4
Amanda: For that money, you get a quiet, competent hatchback with excellent fuel economy and a surprisingly enjoyable ride.
Mike: Yeah, and so what if the interior isn't the best in the pack. I mean, when it comes to subcompacts, price, everyday usability and fuel economy are the most important things, and the Yaris delivers all three in a good-looking hatchback.


text:
Before and after every West Ham United home match, you can visit our riverside boats which is licensed with food on sale as well. All games are ticketed and can be purchased via the forum here http://hammerschat.com/viewtopic.php?f=16&p=19179#p19179(need to be registered to view this part of the Hammers Chat forum).
Ticket prices vary but all information, including times, are available on the forum and done on a game by game basis. Notice will be given, via our social media channels, on when ticket booking threads will go up on the forum to allow members to purchase tickets.
Children are welcome.
Any further questions then you can contact us on the forum !
We look forward to welcoming and meeting as many West Ham United fans and Hammers Chat forum members as possible over the season!!
Thank you for your support!


text:
Social Studies is a program within the History Department designed for students seeking teacher certification in secondary or elementary social studies education. The major consists of a minimum of 42 credit hours in economics, geography, history, and political science. To qualify for a teaching certificate in the state of Michigan, social studies majors must complete at least six credits in each of the four disciplines and a concentration of at least 18 credit hours in one discipline. Transfer and post-graduate students seeking a teachable major in social studies should consult Juanita Davis for an evaluation of their previous work in the CLAS Advising Office located in Mackinac Hall in B-1-140. Her telephone number is (616) 331-8585.
Students may earn the B.A. or the B.S. degree. The B.A. degree requires that a student demonstrate third-semester proficiency in a foreign language (i.e.; a foreign language course at the 201 level). The B.S. degree requires that a student complete Introductory Applied Statistics (STA 215), Research Methods (HST 290), and Technology in Education (EDT 370).
For further information about the Group Social Studies program, go to the History Department website at www.gvsu.edu/history or call the History Department office at (616) 331-3298.
If you are planning a Social Studies Major with an emphasis and/or minor that are in the same content, please work with your Social Studies Advisor to ensure you have enough unduplicated credits.
In addition to the requirements for the Social Studies, the College of Education may have further requirements that a student seeking teacher certification must fulfill. Interested students can inquire about further course requirements at the College of Education website linked to above, the online course catalog for the College of Education, or check in the printed catalog.


text:
2008 Top 100: Profiles 77-100
The 2008 top 100 food and beverage processing companies in the U.S. and Canada are profiled in this annual feature. Find company contact information, major brands, key executives and main product areas.
77. (tie)
Riceland Foods Inc.
2120 S. Park Ave., Stuttgart, AR 72160
Phone: 870-673-5500; Fax: 870-673-3366; Web site: www.riceland.com
Executives: Chrmn: Thomas C. Hoskyn; Pres/CEO: K. Daniel Kennedy; CFO: Harry Loftis
Brands: Chefway, Riceland, Rice 'N Easy
Major Product Areas: Grain mill products, rice, oils
77. (tie)
TreeHouse Foods Inc.
2 Westbrook Corporate Center, Suite 1070, Westchester, IL 60154
Phone: 708-483-1300; Web site: www.treehousefoods.com
Executives: Chrmn/CEO: Sam Reed; Pres/COO: David F. Vermylen; SVP and CFO: Dennis Riordan; General Counsel, Chief Administrative Officer and SVP: Thomas E. O'Neill; SVP of Operations: Harry S. Walsh
Subsidiaries, Divisions: Bay Valley Foods (spun off from Dean Foods)
Brands: Mocha Mix, Rod's, Second Nature; Nature's Goodness, Bennett's, Hoffman House, Roddenberry, mostly private label
Major Product Areas: Pickles, creamers, cheese sauces, soups, baby food
79. Sunkist Growers Inc.
14130 Riverside Drive, Sherman Oaks, CA 91423-2392
(Mailing Address: P.O. Box 7888, Van Nuys, CA 91409-7888)
Phone: 818-986-4800; Fax: 818-379-7405; Web site: www.sunkist.com
Executives: Chrmn: Nicholas L. Bozick; Vice Chrmn: Craig Armstrong; Vice Chrmn: Mark G. Gillette; Vice Chrmn: John M. Grether; Pres/CEO: Timothy J. Lindgren; SVP-Sales and Marketing: Russell L. Hanlin; SVP-Corporate Relations and Administration: Michael J. Wootton; VP &, CFO: Richard G. French; VP-Citrus Juice and Oil Business: Ted R. Leaman III; VP-Fresh Fruit Sales: John B. McGuigan; VP-Law and General Counsel: Thomas M. Moore; VP-Global Marketing & Licensing: Robert J. Verloop
Subsidiaries, Divisions: SunMac Hawaii Ltd., Hawaii; Sunkist Global, LLC, Sherman Oaks, California; Sunkist Pacific Ltd., Japan; Sunkist (Far East) Promotion Ltd., Hong Kong; Sunkist Taylor LLC, Sherman Oaks, California
Brands: Sunkist
Major Product Areas: Citrus, fresh-cut fruit
80. Imperial Sugar Co.
One Imperial Square, 8016 Highway 90-A, P.O. Box 9, Sugar Land, TX 77487-0009
Phone: 281-491-9181; Fax: 281-490-9879; Web site: www.imperialsugarcompany.com
Executives: Vice Chairman: Robert A. Peiser; Pres/CEO: John C. Sheptor; SVP & CFO: H.P. Mechler; SVP-Human Resources: T. Kay Hastings; SVP-Commodities: Patrick D. Henneberry; SVP, General Counsel: William F. Schwer; VP & CIO: George Muller; VP-Industrial Sales: Jack E. Walker; VP-Consumer Sales & Marketing: Greig P. DeBow, Jr.; VP & Treasurer: J. Eric Story; VP-Operations: Graham H. Graham; VP-Technology: Brian T. Harrison
Subsidiaries, Divisions: Diamond Crystal Brands, Savannah, Ga.; Savannah Foods & Industries Inc., Savannah, Ga.; Michigan Sugar Co., Saginaw, Mich.
Brands: Dixie Crystals, Imperial, Holly, Savannah Gold
Major Product Areas: Sugar/confectionery
81. Birds Eye Foods Inc.
90 Linden Oaks, Rochester, NY 14625
Phone: 585-383-1850; Fax: 585-383-1281; Web site: www.birdseyefoods.com
Executives: Pres. & CEO: Dennis M. Mullen; EVP-Ops: Carl W. Caughran; EVP-Mktg. & Bus. Devel.: David E. Hogberg; CFO: Earl L. Powers; SVP-Retail Sales: Robert Montgomery Subsidiaries/Divisions: California & Washington Co., Kennedy Endeavors Inc., Linden Oaks Corp., Pro-Fac, GLK Holdings, BEMSA Holdings, Tim's Cascade Chips
Brands: Bird's Eye, Freshlike , Brooks, Comstock, McKenzie's, McKenzie's Gold King, Southern Farms, Southland, Nalley, Pixie, Snyder of Berlin, Thunder Crunch, Tim's Cascade Style Potato Chips, Husman, La Restaurante, Erin's Naturally Good, Flavor Destinations, Riviera, Mariner's Cove, Bernstein's, Bird's Eye Viola!, California & Washington, Birds Eye Fresh, Tropic Isle, Naturally Good, Thank You, California & Washington Organic.
Major Product Areas: Meat and poultry products, canned, frozen and preserved foods, snack foods, miscellaneous
82. The Hain Celestial Group Inc.
58 S. Service Rd., Melville, NY 11747
Phone: 631-730-2200; Fax: 631-730-2550; Web site: www.hain-celestial.com
Executives: Chrmn, Pres/CEO: Irwin D. Simon; EVP & CFO: Ira J. Lamel; EVP: John Carroll; EVP: Francis W. Daily; EVP: Steven List
Join the discussion
We welcome your thoughtful comments.
All comments will display your user name.
Want to participate in the discussion?Register for free
Log in for complete access.
No one has commented on this page yet.
RSS feed for comments on this page | RSS feed for all comments


text:
Dixon Police
Brittani A. Shaffer, 20, of Dixon; 10:30 p.m. Friday on South Hennepin Avenue; Lee County warrant – possession of a controlled substance; taken to Lee County Jail.
Brian T. Shumack, 39, of Dixon; 4:22 a.m. Sunday in the 100 block of South Galena Avenue; driving under the influence, disobeying a traffic-control device; taken to Lee County Jail.
Andrew M. Near, 20, of Dixon; Sunday in the 600 block of East Third Street; Lee County warrant – failure to appear; posted bond.
Erin K. Fox, 23, of Franklin Grove; 10:42 p.m. Sunday in the 800 block of Franklin Grove Road; driving under the influence of alcohol, improper lane usage, operating an uninsured vehicle, speeding; posted bond.
Lee County Sheriff
Joshua David Cramer, 23, of Davenport, Iowa; 10:12 p.m. Saturday; warrant – contempt – nonpayment; given notice to appear in court.
Stacey A. Jost, 32, of Amboy; 7:32 p.m. Saturday; driving with a suspended license; given notice to appear in court.
Alex J. Papp, 27, of Oswego; 2:11 a.m. Friday; driving with a revoked license; given notice to appear in court.
Kalen M. Kerber, 23, of Rock Falls; 12:27 a.m. Friday; warrant – contempt – nonpayment; given notice to appear in court.
Sterling Police
Billie J. Knight, 24, of Sterling; 10:10 p.m. Sunday at East Fifth and Locust streets; operating an uninsured motor vehicle; given notice to appear in court.
Ogle County Sheriff
Brian J. Speaker, 39, of Rockford; 8:12 p.m. Sunday in the 3000 block of North state Route 251; driving with a suspended license, no insurance; taken to Ogle County Jail.
Mary I. Sexton, 24, of Rockford; Sunday; speeding, McClean County warrant. A passenger in her car, Delia N. Hare, 27, of Rockford, was arrested on a Rockford Police Department warrant; both were taken to Ogle County Jail.
Joseph Smith, 25, of Polo; Friday on state Route 26 and Haldane Road; failure to stop at a stop sign, failure to reduce speed to avoid an accident, driving without a commercial driver's license after striking a vehicle driven by Floriberto Ruiz, 43, of Freeport. Ruiz was charged with driving without a driver's license; both given notice to appear in court.
James W. Huff Sr., 54, of Eutawville, S.C.; Friday; domestic battery warrant; given notice to appear in court.


text:
Ce post est disponible en francais ici.
In a recent project, for the purpose of unit testing, I had to use the InternalsVisibleTo attribute, which extends the scope of the internal qualifier. This allows the separation of the unit testing code assembly from the actual code, without publishing the internals to the "public". This way, you can avoid shipping your unit testing code.
This is an interesting attribute from many points of view, but when using it, you may face this nice error message :
error CS1726: Friend assembly reference 'Dummy' is invalid. Strong-name signed assemblies must specify a public key in their InternalsVisibleTo declarations.
Problem was, my current assembly nor the target assemblies were signed. I tried adding a dummy PublicKey or PublicKeyToken as indirectly suggested here and here, but as many people out here, I don't want to mess with assembly signing at this point of my project.
It turns out that the compiler considers your assembly as "signed" if there is either an AssemblyKeyFile or AssemblyKeyName defined on the assembly, even though both of them are empty.
So, to be able to use AssemblyKeyName InternalsVisibleTo with unsigned assemblies, just remove AssemblyKeyFile or AssemblyKeyName attributes if you don't use them.
My name is Jerome Laban, I am a Software Architect, C# MVP and .NET enthustiast from Montréal, QC. You will find my blog on this site, where I'm adding my thoughts on current events, or the things I'm working on, such as the Remote Control for Windows Phone.
Powered by BlogEngine.NET 188.8.131.52
Theme by Mooglegiant


text:
The information provided here is meant to give you a general idea about each of the medications listed below. Only the most general side effects are included, so ask your doctor if you need to take any special precautions. Use each of these medications as recommended by your doctor, or according to the instructions provided. If you have further questions about usage or side effects, call your doctor.
If it is determined that you had an ischemic stroke within 4½ hours of the beginning of your symptoms, you may be treated with IV clot-busting medications designed to limit damage and possibly restore blood flow to the involved areas of your brain. If it is within approximately 6 hours of the onset of your symptoms, you may be treated with intra-arterial (IA) clot-busting medications. IAs are administered via a groin incision. A catheter is advanced to the clot where medications are given directly to the clot. (These therapies are not used for hemorrhagic strokes.)
Other medications are given after the immediate danger has passed to prevent a second stroke or manage potential damage. Medications may include:
Recombinant tissue plasminogen activator (rt-PA)
Common name: Alteplase
Rt-PA is used for treating ischemic stroke. Other clot-busters are used for treating heart attacks and blood clots in other organs. These drugs dissolve the chemicals that hold blood clots together. Therefore, these drugs must be used in only the right circumstances and must be carefully controlled.
Possible side effects include:
Common names include:
These drugs prevent blood from clotting, rather than dissolving a clot after it has formed. Therefore, they are used to prevent another stroke. In some cases, anticoagulants are used to prevent a first stroke if a person is at high risk. These drugs may be used if the cause of the stroke or risk factor for having a stroke is atrial fibrillation or heart valve disease.
Given by injection, heparin works immediately to prevent blood clotting. If there is a risk of bleeding from an infected area or a large brain-damaged area, this medication may not be used.
Possible side effects include:
Warfarin prevents formation of a blood-clotting factor by interfering with vitamin K metabolism. It takes several days to have an effect. Warfarin is frequently given along with heparin. The heparin is discontinued when the warfarin is fully active. Warfarin can be taken by mouth. But, it must be controlled within very close limits to prevent unwanted bleeding.
The dose of warfarin varies widely and is regulated by frequent blood tests that check on clotting ability. These tests are done at least weekly at the beginning of treatment. This is because there are so many interactions that can change its effect. Warfarin decreases the recurrence rate of embolic stroke in people with atrial fibrillation, which is a common cause of embolic stroke.
Possible side effects include:
Dabigatran is a medication that helps to prevent blood clots. It can be taken by mouth and does not require frequent blood tests.
Possible side effects include:
Rivaraoxaban is a medication used to decrease the risk of strokes in people with irregular heartbeat known as non-valvular atrial fibrillation.
Possible side effects include bleeding.
Apixaban is a medication used to decrease the risk of strokes in people with irregular heartbeat known as non-valvular atrial fibrillation.
Possible side effects include bleeding.
Common names include:
Aspirin, in addition to its pain-relieving effect, decreases blood clotting by affecting platelets. This medication is able to reduce recurring heart attacks by about 25%. Its effect on embolic stroke is about the same.
Possible side effects include:
This medication is used to reduce risk of stroke in people who have had transient ischemia attacks (TIA) or a prior stroke due to blood clots. Dipyridamole may be more effective than aspirin alone. Side effects include:
Clopidogrel is used to prevent heart attack and stroke. Clopidogrel can be used in people who cannot take aspirin or who have a coronary stent. Possible side effects include:
Nerve-protecting drugs help prevent additional nerve-cell damage caused by the chemicals released from dying brain cells. These drugs are promising, but not yet routinely used because they are still being tested. One example is minocycline, a commonly prescribed antibiotic. It may help to improve function when given after a stroke.
In treating stroke, doctors may give you other drugs as needed to:
If you are taking medications, follow these general guidelines:
Anticoagulation therapy for acute stroke. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T474326/Anticoagulation-therapy-for-acute-stroke. Updated October 28, 2016. Accessed September 29, 2017.
Antiplatelet agents for secondary prevention of stroke. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T163233/Antiplatelet-agents-for-secondary-prevention-of-stroke. Updated November 4, 2016. Accessed September 29, 2017.
Bushnell C, McCullough LD, Awad IA, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(5):1545-1588. Available at: http://stroke.ahajournals.org/content/early/2014/02/06/01.str.0000442009.06663.48.full.pdf. Accessed September 29, 2017.
Carpenter, C, Keim S, Milne W, et al. Thrombolytic therapy for acute ischemic stroke beyond three hours. J Emerg Med. 2011;40(1):82-92.
Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2011;42(1):227-276. Available at: http://stroke.ahajournals.org/content/early/2010/10/21/STR.0b013e3181f7d043.full.pdf. Accessed September 29, 2017.
Stroke (acute management). EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T143427/Stroke-acute-management. Updated July 27, 2017. Accessed September 29, 2017.
Thrombolytics for acute stroke. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T114577/Thrombolytics-for-acute-stroke. Updated October 28, 2016. Accessed September 29, 2017.
10/22/2007 DynaMed Plus Systematic Literature Surveillancehttp://www.dynamed.com/topics/dmp~AN~T143427/Stroke-acute-management: Lampl Y, Boaz M, Gilad R. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology. 2007;69(14):1404-1410.
Last reviewed September 2017 by EBSCO Medical Review Board Rimas Lukas, MD Last Updated: 12/20/2014


text:
Now that Fourth of July weekend is behind us the summer is in full swing, your interns are finally getting settled in.
In fact, they've probably adjusted to the good natured hazing they've experienced on the trading desk — like testing their resourcefulness by asking them to bring you a root beer float.
Perhaps the time is right to sit them down for a little heart-to-heart chat about the perils and opportunities that lie ahead of them.
With a little time and effort, you can be their Virgil in Wall Street's underworld: The Internship.
By Ash Bennington
Posted 5 July 2011


text:
RF Technologies® Releases Version 8 Software with Smart ID™ Location Detection Upgrade
Flexible room- or area-level locationing options enable more efficient response to resident calls
Jan 16, 2013, 11:01 ET
BROOKFIELD, Wis., Jan. 16, 2013 /PRNewswire/ -- RF Technologies®, a leading provider of radio frequency identification (RFID) healthcare safety and security solutions, has upgraded its Smart ID Location Detection technology as part of its Version 8 software release to provide accurate room- or area-level locationing when senior living residents summon help from a wireless pendant.
Smart ID Location Detection is a feature of the Code Alert® Quick Response® Plus Wireless Call Solution. When a resident pushes a pendant button, wall-mounted repeaters collect the pendant's signal. The resident's name and location are then promptly transmitted to the caregiver for a faster response.
"Smart ID is a valuable aid in resident care. With our enhancements to location detection, residents can have confidence and added peace of mind that, when they need it, help is on the way," said Sean Daugherty, senior vice president and general manager for solutions development and sales. "The flexibility of Smart ID enables a community to choose which solution best accommodates staff, residents and workflow."
Accurate room-level detection enables caregivers to respond promptly, giving residents greater sense of security. During installation, coverage areas are "mapped" with survey points so when a pendant is activated, its location can be calculated based on comparison to the mapped points.
Area-level detection is a cost-effective solution for communities that require locationing narrowed down to common areas or living areas. Community mapping isn't required, making installation simple and efficient.
Through Code Alert software, control stations display the resident's location during an emergency event. Remote caregivers can also receive alerts from a variety of optional devices, including pagers, wireless phones that show emails and text messages, and Quick Look™ LED displays.
Quick Response Plus enables residents to call for assistance from anywhere in a community, inside or outside, using pendants and a variety of stationary call devices such as pull cords and call buttons. Mobile pendants are water-resistant for added safety in the shower, and can be worn on a breakaway necklace or on a belt clip. Devices can be added as needed when communities expand or are remodeled, resulting in a scalable and flexible investment.
Additional features include integration with the Code Alert Wandering Management Solution, easy-to-use software and a touch-screen monitor, alarm escalation, and reporting capabilities. The call solution uses the reliability and scalability of the Inovonics EchoStream® product line.
About RF Technologies
RF Technologies is celebrating its 25th year designing and delivering comprehensive, integrated RFID-based safety and security solutions for senior care communities and hospitals, including Code Alert® Wandering Management and Quick Response® Wireless Call, Sensatec® Fall Management, and Safe Place® Infant, Pediatric, and Elopement Management. RF Technologies is credited with inventing the first RFID infant security system, which was developed by nurse clinicians. With more than 10,000 installations, it was the first in the industry to offer remote monitoring, RF consulting, 24/7 technical support by internal staff specialists, and a nationwide service team. Learn more at www.rft.com.
SOURCE RF Technologies


text:
A West Chicago woman was charged with drunk driving after the vehicle she was driving was involved in an accident in Oswego that killed her passenger, police said today.
The accident happened at 12:02 a.m Sunday in the 5000 block of Minkler Road in Kendall County, police said.
Kristen M. Leonard, 31, of High Lake Avenue in West Chicago, was driving the vehicle when it struck a guardrail on the shoulder of the road, police said.
The accident killed Jason B. Callahan, 38, of Yorkville. Callahan owned the vehicle but was a passenger at the time and was pronounced dead at the scene, police said.
Leonard was taken to Rush-Copley Medical Center for treatment. She is expected to be moved to the Kendall County Jail upon her release, police said.
She was charged with aggravated driving under the influence resulting in a death, aggravated driving under the influence causing great bodily harm, improper lane usage and failure to reduce speed to avoid an accident, police said. Oswego police are investigating.
firstname.lastname@example.com | Twitter: @ChicagoBreaking


text: In February of 2011, Robert M. Kaplan, Ph.D. joined the National Institutes of Health (NIH) Office of the Director as Associate Director for Behavioral and Social Sciences and Director of the Office of Behavioral and Social Sciences Research (OBSSR). Prior to working for government, Kaplan was Distinguished Professor of Health Services at UCLA and Distinguished Professor of Medicine at the UCLA David Geffen School of Medicine where he was PI of the California Comparative Effectiveness and Outcomes Improvement Center. He led the UCLA/RAND health services training program and the UCLA/RAND CDC Prevention Research Center. He was Chair of the Department of Health Services from 2004 to 2009. From 1997 to 2004 he was Professor and Chair of the Department of Family and Preventive Medicine, at the University of California, San Diego. He is a past President of several organizations, including the American Psychological Association Division of Health Psychology, Section J of the American Association for the Advancement of Science (Pacific), the International Society for Quality of Life Research, the Society for Behavioral Medicine, and the Academy of Behavioral Medicine Research. He is a Past Chair of the Behavioral Science Council of the American Thoracic Society. Dr. Kaplan is a former Editor-in-Chief of two different academic journals: Health Psychology and the Annals of Behavioral Medicine. He is the author, co-author or editor of more than 18 books and approximately 490 articles or chapters. His work has been cited in more than 25,000 papers and the ISI includes him in the listing of the most cited authors in his field (defined as above the 99.5th percentile). In 2005 he was elected to the Institute of Medicine of the National Academies of Sciences.


text:
Umstatt, Hans Peter (17th-18th centuries)
Hans Peter Umstatt moved from Krefeld, Germany, to Germantown, Pennsylvania, in 1685. His daughter Eva married the immigrant Hendrick (Heinrich) Pannabecker. His son Johannes (John) Umstatt moved in 1702 or shortly after to Perkiomen Township along the Skippack. C. Henry Smith assumes that the Umstatts were Mennonites, and this is probable since later descendants called Umstead were to be found in the Mennonite Church in Montgomery County, Pennsylvania.
Mennonite Quarterly Review VII (1933): 234 ff.
Smith, C. Henry. The Menunonite Immigration to Pennsylvania. Norristown, 1929: 94, 106, 114, 121, 139 note 23.
|Nanne van der Zijpp
|Date Published
Cite This Article
MLA style
Zijpp, Nanne van der. "Umstatt, Hans Peter (17th-18th centuries)." Global Anabaptist Mennonite Encyclopedia Online. 1959. Web. 12 Nov 2018. http://gameo.org/index.php?title=Umstatt,_Hans_Peter_(17th-18th_centuries)&oldid=143464.
APA style
Zijpp, Nanne van der. (1959). Umstatt, Hans Peter (17th-18th centuries). Global Anabaptist Mennonite Encyclopedia Online. Retrieved 12 November 2018, from http://gameo.org/index.php?title=Umstatt,_Hans_Peter_(17th-18th_centuries)&oldid=143464.
Adapted by permission of Herald Press, Harrisonburg, Virginia, from Mennonite Encyclopedia, Vol. 4, pp. 772-773. All rights reserved.
©1996-2018 by the Global Anabaptist Mennonite Encyclopedia Online. All rights reserved.


text: Copper and leather bracelet. Hand hammered with a stone texture, this organic bracelet is handmade from thick solid copper pipe; approximately 1 inch (25 mm) wide by 1.67 inches (42 mm) long and slightly curved for your wrist. Protective coating of Renaissance wax applied to both front and back. 3 mm natural brown round leather cord is adjustable to fit most any wrist and is secured by 1 mm natural brown round leather cord with pure copper bead ends. Simply tug on loop near clasp or free ends of both cords for a custom fit - and then cut off any excess length for a more esthetically pleasing look. Copper-toned base metal swivel lobster clasp for easy wearing and removal. Please note: Bracelets 'A', 'B', 'C', and 'D' made with lightweight 24-gauge solid copper. All other bracelets ('E' through 'J') in this series were made from thicker copper tubing, so the copper slab is roughly twice the thickness of bracelets 'A' through 'D'. 5th photo is of bracelet 'E' and is included here for illustration purposes only.


text:
You are hereNaruto
You are going to watch Naruto english dubbed / subbed online for free.This episode is our 1253 release.
Request Anime | Report Broken Link
Genre: Action, Comedy, Martial Arts, Shounen, Super Power
Sequel: Naruto Shippuuden
Side Story: Naruto OVA's and Movies
Manga: Read Naruto Manga Online
Naruto Manga
Memes: Naruto Memes
Episodes: 220
Type: TV Series
Age Rating: Teen +13
Voice Available:
Subtitle Available:
English: Naruto
Naruto Episodes Online
Before Naruto was born, a great demon fox had attacked the Hidden Leaf Village. A man known as the 4th Hokage sealed the demon inside the newly born Naruto, causing him to unknowingly grow up detested by his fellow villagers. Despite his lack of talent in many areas of ninjutsu, Naruto strives for only one goal: to gain the title of Hokage, the strongest ninja in his village. Desiring the respect he never received, Naruto works towards his dream with fellow friends Sasuke and Sakura and mentor Kakashi as they go through many trials and battles that come with being a ninja. Based on the manga by Kishimoto Masashi.You can also watch naruto episodes from this awesome site in HD quality
Latest Anime Series
Click on to an anime cover to watch it online for free!


text:
Hank Ballard, Creator of The Twist
By: Legacy Staff
6 years ago
Most people today associate "The Twist" with Chubby Checker, but the song was actually first recorded by Hank Ballard, born on this day in 1927.
Born in Detroit, Hank Ballard grew up in Bessemer, Ala., with his aunt and uncle following the death of his father. Though he sang in the gospel choir at church, he cites his most important early influence as singing cowboy Gene Autry, whose song "Back in the Saddle Again" was a big hit in 1939.
As a teenager, Ballard ran away from home and moved back to Detroit. In 1951 he started a doo-wop group before meeting multi-instrumentalist and bandleader Johnny Otis, who invited Ballard to join The Royals, a band already under contract to Cincinnati-based R&B label Federal Records. The group changed its name to The Midnighters and released their first single, "Get It," in 1953.
Unfortunately, many radio stations refused to play it.
It was a circumstance that would repeat itself throughout Hank Ballard's career. His risqué lyrics were only part of the problem – in the 1950s, most white radio stations shied away from playing R&B and rock recorded by black artists, which is why many of the artform's black songwriting innovators never become as well known as the white acts that covered them – people like Elvis Presley, Bill Haley and Jerry Lee Lewis.
Ballard wrote the 1954 Midnighter's release "Work With Me, Annie," but it was banned from the airwaves by the FCC for its suggestive lyrics. The government may not have approved, but they couldn't keep it out of the hands of white teenagers. The record rose to No. 1 on the R&B charts and stayed there for nearly two months, selling nearly a million copies. Follow ups "Annie Had a Baby" and "Annie's Aunt Fannie" were also restricted from radio and were also big hits. An answer song by Etta James called "The Wallflower" – more popularly known as "Roll With Me Henry" was later a hit for Georgia Gibbs with new, less risqué lyrics as "Dance With Me Henry." Now called Hank Ballard and the Midnighters, Ballard's group responded with "Henry's Got Flat Feet." All used the same melody and 12-bar blues progression.
While some artists toned down their material for airplay, Hank Ballard and the Midnighters went the opposite direction with songs like "Sexy Ways." The group continued garnering lesser hits, including 1960's "Let's Go, Let's Go, Let's Go" and the Grammy-nominated "Finger Poppin' Time," but the song that remains most firmly lodged in pop culture memory today wasn't a big hit for Ballard.
"The Twist" was released by Hank Ballard and the Midnighters as a B-Side to "Teardrops on Your Letter" in 1959, but charted only at a modest No. 16 – this despite the new dance the band had come up with to perform along with the song. But when it was recorded the next year by Chubby Checker, his version rocketed up the charts. It became the only song to reach No. 1 twice on the Billboard Hot 100 (in 2008, Billboard named it the biggest hit of all time), spawned a dance craze, and was even credited with getting adults out on the dance floor with teenagers. It made Checker's career, leading him to record follow-ups like "Twistin' U.S.A.," "Slow Twistin'," "Let's Twist Again" and a collaboration with 1980s hip-hop act The Fat Boys called "The Twist (Yo, Twist!)."
At right: Hank Ballard is shown at the Rock and Roll Hall of Fame Awards in New York on Jan. 18, 1990. Ballard, the singer and songwriter whose hit The Twist ushered a nationwide dance craze in the 1960s, died Sunday, March 2, 2003, at his home, friends said. (AP Photo / Ron Frehm)
Was Ballard bitter over Checker's success? Far from it – he thanked Chubby Checker (and Dick Clark) for helping make the song popular. And why not? Presumably Ballard earned a fortune in songwriting royalties.
Hank Ballard and the Midnighters disbanded in 1965, and Ballard pursued a solo career. He worked with Stevie Ray Vaughan, The Midnighters were inducted into the Rock and Roll Hall of Fame, and Ballard toured with them only a year before his death on March 2, 2003, of throat cancer. He was 75 years old.


text:
Views: 291
You're no slouch yourself, Joan. Don't sell yourself short, please.
As for me, I know what I know. When I feel like I know enough to make something resembling an intelligent comment, you and the rest of A|N get my best shot. I just hope I'm contributing something positive and not just making noise (sometimes I DO wonder!).
I agree with Loren. Don't short change yourself. As to being surrounded by giants, I disagree. You're not surrounded by them. Like all the rest of us, we're doing nother more than standing on their shoulders.
What you said, Pat. We stand on the shoulders of everyone from Thomas Jefferson and James Madison to Robert Ingersoll, Sam Harris and the incomparable Christopher Hitchens, and that is only the ultra-short list. They helped us along and I hope that we in turn can help others, one way or another.
If all I do in this world is make a positive difference to someone else ... well, that works pretty good for me.
You know, the older I get, the more I look back on my postings and am embarrassed by the typos I leave for the rest of the world to see. "we're doing nother more" as opposed to "nothing more." Certainly is conclusive evidence I'm no spring chicken.
I like what you said Loren. "If all I do in this world is make a positive difference to someone else ... well, that works pretty good for me." I could not agree more.
Joan, you and everyone here make a profound difference for me. Thank you.
I feel the same way Joan. I'm learning a lot from you wise peeps, for which I'm grateful. At the same time I feel intimidated.
Before I came to the internet, when I compared my intelligence and knowledge of important things, to those around me, it was obvious that I was in the top 0.1%.
When I joined http://www.lifeaftermormonism.net/ I met people that had escaped mormonism and were thus considerably more intelligent than the average. However, I still felt I could hold my own with them.
After listening to many ex-mormons and arguing with some of them, I became annoyed with many of them, that still had a desire to believe in a god or something after death. My annoyance got to the level that I now don't go to that site at all.
Atheist Nexus is my home now. This is where the brightest of the bright appear to be, but I find myself trying to deal with the fact that I'm at a great disadvantage, at least as to my ability to express myself, and sometimes intellectually. Giants indeed. Still, it's worth it to be where I can gain new knowledge and better ways of thinking at an accelerated rate.
This discussion reminds me of the time when we will contact a race from another planet that are a million years more advanced than us. We will probably feel like monkeys (or less), when we compare ourselves to them, but it will still be beneficial to receive what wisdom they will pass to us.
Thank you Melinda. I appreciate you also. I receive complements and agreements from a number of people here from time to time, but it's still hard to keep my insecurity from shutting me down.
Melinda, I think you're no slouch in the intelligence department, but you are also nice. And, in my book, niceness often trumps intelligence. If someone seems intelligent, but is not nice, I often question how intelligent he really is, and stop paying attention to him.
I have no problem with someone responding to being attacked.
When I say being nice I do not mean being submissive or forgiving everything. I do not mean being a yes-man.
© 2018 Atheist Nexus. All rights reserved. Admin: The Nexus Group. Powered by